Molecular Data Stock

Molecular Data EBIT per Share

Delisted

The EBIT per Share of Molecular Data (MKD) as of Aug 4, 2026 is -14.28 CNY. In the previous year, EBIT per Share was -9.28 CNY — a change of 53.90% (lower).

EBIT per Share

-14.28CNY

YoY

53.90%

Last updated:

EBIT per Share of Molecular Data is 2026 -14.28 CNY. EBIT per Share of Molecular Data was 2025 -9.28 CNY. It decreases by 53.90% lower compared to the previous year.
Access this data via the Eulerpool API

Molecular Data Stock analysis

What does Molecular Data do? Molecular Data Inc. is a leading technology company specializing in the use of big data, artificial intelligence (AI), and blockchain technology in the chemical and pharmaceutical industry. The company was founded in 2014 and is headquartered in Shanghai, China. Molecular Data Inc. has a comprehensive database consisting of millions of chemical compounds, which aids chemists, pharmaceutical companies, and researchers in identifying, exploring, and developing new drugs. The company places great importance on integrating data and technologies to accelerate and improve drug development. Molecular Data Inc. provides cloud-based solutions based on the analysis of big data through AI algorithms and blockchain technology. It offers platforms, as well as consulting and training services, to support customers in efficiently utilizing the platforms. The company's main products include the MDL platform, which enables the integration of data, knowledge, and algorithms to accelerate drug development processes. The MDL platform is a cloud-based system that provides access to a database of millions of compounds and allows users to receive real-time results. Molecular Data Inc. also offers a blockchain-based platform for the chemical and pharmaceutical industry, enhancing the transparency and security of data and information. The platform facilitates secure data exchange between different companies and regulatory authorities, providing improved control and monitoring of data. Another important service provided by Molecular Data Inc. is consulting and training for companies in implementing big data, AI, and blockchain into their workflows. The company aims to equip its customers with the necessary skills and knowledge to optimize their business processes and increase competitiveness. Molecular Data Inc. is divided into several divisions to ensure efficient collaboration and product development. These divisions include research and development, sales and marketing, finance and administration, and information technology. The company strives to expand its business through strategic partnerships and acquisitions. It has already completed several acquisitions to strengthen its expertise in big data, AI, and blockchain. Through these strategic measures, the company has been able to offer its customers a comprehensive range of products and services to enhance performance and increase competitiveness. Overall, Molecular Data Inc. is a significant company in the chemical and pharmaceutical industry that specializes in the integration of data and technologies to enhance process efficiency and speed. The company aims to strengthen its position as a market leader through innovation and strategic partnerships. Molecular Data is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Molecular Data stock

EBIT per Share of Molecular Data is -14.28 CNY in 2026.

EBIT per Share of Molecular Data changed from -9.28 CNY to -14.28 CNY, representing a 53.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Molecular Data since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

Income Statement — Molecular Data

All Key Metrics — Molecular Data